First American dosed with Oxford-AstraZeneca phase three COVID-19 vaccine speaks out

First American dosed with Oxford-AstraZeneca phase three
COVID-19 vaccine speaks out 1

Oxford University, in partnership with AstraZeneca, started testing the first U.S. volunteers as part of its phase three COVID-19 vaccine trial. CBS News chief medical correspondent Dr. Jon LaPook joins “CBS This Morning” with an exclusive interview with an American in the Oxford-AstraZeneca vaccine trial.

Read the Full Article

Prepare Now Before its too Late

Discover where products are available & compare prices

Americans divided over armed civilians who flock to protests
Senate Republicans look to roll out targeted coronavirus relief bill

You might also like
Menu